This session will examine several regulatory issues that impact US and global trial operations from multiple perspectives. Topics include US and Latin American trial issues, OTC drugs and personal care products used in clinical trials, and new Certificate of Confidentiality rules. There will also be time set aside for Q&A with the expert panel.
Contact Hours/CEUs: TBD
- Anne Blanchard, CCRA, CEO, Clinical Operations Manager, Blanchard & Associates
- Michael Caswell, PhD, CCRA, CCRC, Vice President, Clinical Evaluations, Consumer Product Testing Company, Inc.
- Jan Peterson, MS, CCRA, RAC, MICR, ASQ CBA, Senior Regulatory Affairs Manager, Project Director, Emmes Corporation
- Sandra (Sam) Sather, MS, BSN, CCRA, CCRC, Vice President, Clinical Pathways, LLC